Interview with Bloomberg Senior Biotech Analyst, Dr Sam Fazeli
Dear Friends of o2h group,
We are delighted to announce that we are back with o2h ChaiTime Season 3 starting with our season’s first ChaiTime webinar on 5th March 2021, Friday @ 3.00pm GMT (10.30am EST/ 8.30pm IST).
We have all seen death rates decrease and vaccinations increase, does this mean that we are at the tailend of the pandemic? Well we all hope so; one of the trends that we have seen is certain industries to come through this stronger. The SPDR S&P Biotech ETF is making fresh highs; investors have been forced fed courses in epidemiology and biology and realise the importance of science on both the economy and society.
I am very excited to have the opportunity to have an exclusive 1-1 interview with Dr Sam Fazeli, a senior analyst @Bloomberg. He is one the world's leading and most respected biotech analysts in London with a career in the sector that spans over 20 years. He recently published an article on Bloomberg “Britain Deserves Some Credit for Leading the Covid-19 Fight’ which I will be quizzing him on during the webinar”. Given the ‘flack’ the government has received over its handling of the pandemic I was interested in his perspective as well as whether he believes the focus on biotech investing will be long-lasting and his view on public markets.